Skip to main content
. 2019 Nov 4;6(12):ofz475. doi: 10.1093/ofid/ofz475

Table 3.

Comparison of Outcomes

Outcomes Oritavancin Vancomycin P Value
Unadjusted Outcomes
30 day subsequent admission rates 5.80% 16.20% .002
Mean healthcare costs $10 096 (8865) $12 779 (28 773) .30
Adjusted Outcomes
30 day subsequent admission rates 6.10% 16.20% .003
Mean healthcare costs $12 695 $12 717 .98